Energous expects to report revenue for the quarter ended June 30, 2025, totaling in excess of $900,000, and expects to deliver the lowest quarterly net loss in the last ten years.

Eupraxia plans to enroll a minimum of 60 patients in the Phase 2b portion of the RESOLVE study in up to 25 sites globally, assessing tissue health measured by biopsy (EoEHSS and PEC scores), symptom ...

疾管署發言人羅一鈞今（8）日表示，上週無新增腸病毒重症或死亡病例，評估新生兒腸病毒疫情已於 6 月中旬達高點，但預估整個7月都是流行期，且不排除持續到 8 月，加上暑假活動密集可能再度推升疫情，提醒家長不可輕忽。